A federal judge has recused himself from a UnitedHealthcare proton therapy lawsuit; researchers are trying to develop a lifetime flu vaccine; researchers create an inexpensive 3D printed microscope for medical diagnostics in developing countries.
Yesterday, US District Judge Robert Scola recused himself from deciding 1 of the 2 lawsuits against UnitedHealthcare that have been filed in the last 2 months over the company denying coverage for proton radiation therapy to patients with cancer, Kaiser Health News reported. Scola's recusal was due to his personal experience with the treatment. In an order of recusal, he wrote that denying a patient the treatment was "immoral and barbaric." Insurers have long been reluctant to pay for the treatment in the past. A new approach that teaches the body to identify a portion of the flu virus that remains unchanged could lead to a lifetime flu vaccine, according to MedicalXpress. While testing on lab animals has shown early signs of success, the vaccine needs to be made more specific and applied in larger studies before it can be tested on humans. The technique uses a protein that can bind to a precise spot on the flu virus, called a monoclonal antibody, to help the immune system target the unchanging protein of the virus and attack it.Researchers have printed a 3-dimension portable, high resolution microscope that is inexpensive and can be easily replicated, making it useful for medical diagnostics in developing countries, ScienceDaily reported. The microscope doesn’t require any special staining or labels and could potentially detect diseases such as malaria, sickle cell disease, diabetes, and others. The instrument could additionally be used in research, education, defense, and manufacturing. Researchers say that the device is ready for practical use and a reproduction could be made at a fraction of the price of similar microscopes.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Use of AI Lets Health System Find Lung Cancer at Early Stages
March 8th 2025Artificial intelligence (AI) helps a Sarasota, Florida, health system catch lung nodules that appear on CT scans for patients treated for scores of conditions, allowing them to be referred for a possible lung cancer diagnosis.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen